首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1213篇
  免费   92篇
  国内免费   1篇
  1306篇
  2022年   6篇
  2021年   14篇
  2020年   13篇
  2019年   12篇
  2018年   15篇
  2017年   16篇
  2016年   16篇
  2015年   30篇
  2014年   45篇
  2013年   71篇
  2012年   60篇
  2011年   58篇
  2010年   35篇
  2009年   38篇
  2008年   62篇
  2007年   61篇
  2006年   64篇
  2005年   59篇
  2004年   61篇
  2003年   55篇
  2002年   61篇
  2001年   16篇
  2000年   14篇
  1999年   21篇
  1998年   20篇
  1997年   8篇
  1996年   8篇
  1995年   13篇
  1994年   12篇
  1993年   12篇
  1992年   17篇
  1991年   16篇
  1990年   14篇
  1989年   16篇
  1988年   10篇
  1987年   14篇
  1986年   6篇
  1985年   15篇
  1984年   25篇
  1983年   18篇
  1982年   26篇
  1981年   11篇
  1980年   6篇
  1978年   6篇
  1977年   7篇
  1976年   9篇
  1975年   9篇
  1974年   9篇
  1973年   8篇
  1968年   6篇
排序方式: 共有1306条查询结果,搜索用时 15 毫秒
1.
The innate host defense against influenza virus is largely dependent on the type I interferon (IFN) system. However, surprisingly little is known about the cellular source of IFN in the infected lung. To clarify this question, we employed a reporter mouse that contains the firefly luciferase gene in place of the IFN-β-coding region. IFN-β-producing cells were identified either by simultaneous immunostaining of lungs for luciferase and cellular markers or by generating conditional reporter mice that express luciferase exclusively in defined cell types. Two different strains of influenza A virus were employed that either do or do not code for nonstructural protein 1 (NS1), which strongly suppresses innate immune responses of infected cells. We found that epithelial cells and lung macrophages, which represent the prime host cells for influenza viruses, showed vigorous IFN-β responses which, however, were severely reduced and delayed if the infecting virus was able to produce NS1. Interestingly, CD11c+ cell populations that were either expressing or lacking macrophage markers produced the bulk of IFN-β at 48 h after infection with wild-type influenza A virus. Our results demonstrate that the virus-encoded IFN-antagonistic factor NS1 disarms specifically epithelial cells and lung macrophages, which otherwise would serve as main mediators of the early response against infection by influenza virus.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.
10.
Omega-3 polyunsaturated fatty acids (n-3 or omega-3 PUFAs) and melatonin receptor agonist ramelteon (RMT) both display antidepressant effects, while their cellular effects on anti-oxidative and neuroprotective mechanisms might be different. In this study, we aimed to decipher the individual and synergistic actions of n-3 PUFAs and RMT, as compared with the conventional antidepressant fluoxetine (FLX), in a cellular model of oxidative stress, which might play an important role in the pathophysiology of depression and associated disorders. We investigated the rescue and prevention effects of FLX, RMT, and n-3 PUFAs, e.g., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), by using cell viability in SH-SY5Y cells under oxidative stress along with measurements of key cellular markers of oxidative stress, inflammatory, and neuroprotection. The results revealed that the RMT and EPA combination significantly increased the cell viability in a dose-dependent manner. RMT showed preventive effects, FLX and DHA possessed rescue effects, while EPA showed both rescue and preventive effects. We observed the dose-dependent activation and translocation of nuclear factor-κB to the nucleus augmented by the expressions of peroxisome proliferator activator receptor-gamma, tyrosine hydroxylase, c-Fos expression, and reactive oxygen species, implying that RMT and EPA combination reversed oxidative and neuroinflammatory pathophysiology and protected the neuronal cells from further damage. The results demonstrated that RMT and EPA synergistically provide effective neuroprotective, anti-oxidative/inflammatory effect against oxidative stress. Our study provides pre-clinical evidence to conduct future clinical trials of using n-3 PUFAs/RMT combination in depressive disorders.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号